Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
about
Metastatic disease from uveal melanoma: treatment options and future prospectsGuidelines of the Brazilian Dermatology Society for diagnosis, treatment and follow up of primary cutaneous melanoma--Part ITo what extent are current guidelines for cutaneous melanoma follow up based on scientific evidence?Follow-up in melanoma patientsSystematic review of the use of granulocyte-macrophage colony-stimulating factor in patients with advanced melanomaStudy design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT).Discrepant alterations in main candidate genes among multiple primary melanomasImprovement of overall survival in stage IV melanoma patients during 2011-2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR).Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence.HF ultrasound vs PET-CT and telethermography in the diagnosis of In-transit metastases from melanoma: a prospective study and review of the literature.Evaluating biomarkers in melanoma.A single-dose mass balance and metabolite-profiling study of vemurafenib in patients with metastatic melanoma.NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas.Retrospective analysis of drug utilization, health care resource use, and costs associated with IFN therapy for adjuvant treatment of malignant melanomaAdapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective studyRadiocolloid-based dynamic sentinel lymph node biopsy in penile cancer with clinically negative inguinal lymph node: an updated systematic review and meta-analysis.Laser and light-based therapy for cutaneous and soft-tissue metastases of malignant melanoma: a systematic review.Serum markers in early-stage and locally advanced melanoma.The efficacy and safety of nivolumab in the treatment of advanced melanoma: a meta-analysis of clinical trials.Cutaneous melanoma follow-up: appropriateness of requests for ultrasound tests--the S.Gallicano National Referral Centre Experience."Better do not touch" and other superstitions concerning melanoma: the cross-sectional web-based survey.Novel treatments for melanoma brain metastases.Positron emission tomography in the follow-up of cutaneous malignant melanoma patients: a systematic reviewPredictive molecular markers in metastases to the central nervous system: recent advances and future avenues.A review of sentinel lymph node biopsy for thin melanoma.Vemurafenib for the treatment of BRAF mutant metastatic melanoma.Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma.Targeted therapy in melanoma - the role of BRAF, RAS and KIT mutations.Nivolumab: A Review in Advanced Melanoma.The importance of surgical margins in melanoma.The immune system and cancer evasion strategies: therapeutic concepts.Importance and methods of searching for E-publications ahead of print in systematic reviews.Key regulators of apoptosis execution as biomarker candidates in melanomaBRAF/NRAS wild-type melanoma, NF1 status and sensitivity to trametinib.Seminal vesicle metastasis of cutaneous malignant melanoma: An unusual and challenging presentationEANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition.Real-world treatment patterns and outcomes among metastatic cutaneous melanoma patients treated with ipilimumab.Clinical use of ipilimumab for metastatic melanoma in Spain: towards a more consistent approach.Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years.
P2860
Q26738377-86470251-3420-4DCA-A7F2-000F18B972ACQ26770468-21920490-060C-4125-A07B-2E05CF93DA3EQ26828637-FAF096D0-1500-4D21-8E88-56867E7BD91DQ26999904-3F50D7E5-6D79-4448-8414-652736D81B0BQ28067023-01339F10-5EAB-4434-B1FD-5055D19AF05EQ30384829-A98E571A-F6AC-418A-9EF0-BD9074D9C209Q30578299-FF5C06BA-21AD-4855-9C51-57DCAAE0E782Q31144246-42426F4E-54E6-4F63-8ADB-E776E05564C4Q34235463-313DC553-E87D-4397-B5FD-72A37C06C15DQ34582066-D16E6979-2A04-40CD-AF9C-3B9F702539BAQ35005677-CB9C102E-CD67-489E-940E-7DEB980E20B9Q35073752-A8F45FB7-BDAA-4568-AED4-416B5C85F99CQ35885523-F1B86AD3-39C6-4AB7-8CAF-44D1690659FDQ35891979-866ED5DB-1E78-4751-8A45-48D301790F0DQ36028552-040C5528-ACB3-4CB2-8425-8F6B3703AB45Q36117732-1314F24C-66BB-4B23-9E1E-01D526783F21Q36313498-3C38593B-1F6B-4017-8F27-8C27313F6AE8Q36352802-D38AE1FE-4B85-4A6C-8CED-F452B7C66DCFQ36716229-AB5572AA-612D-4F82-B243-4DA44CAFF68EQ37365517-AE00BE7C-8724-4557-A8BD-90E9BC2EC2F2Q37416290-E2BBE07B-63E9-4BF5-B39E-FCD63B802235Q38146716-E505D817-3A17-4C69-A51B-F4FA6D9135CEQ38174901-E5845B04-5652-486E-A200-25D9B349C9A7Q38257364-95F1F536-B535-403C-AF70-99F3D8C49136Q38264727-9FCF9834-F728-44E2-A4BE-EAEAF41B09E3Q38357122-4398CBDB-20FC-4ECC-99CB-FDD892A2A88AQ38549236-018D0ECD-C5F2-4475-A4EB-50950AC13074Q38555837-27286928-8AF9-4D5E-929D-E3EDD7C5E32BQ38556639-542C990D-60CE-4CE8-BD1D-62220F611B22Q38667983-63BB9AAC-F532-4AD5-9503-1C7DCE4ECEFBQ38691172-14DEBC09-EDB6-400F-8374-0B6511E819DEQ38749153-6369BE06-77E6-4956-9B0A-378D66C3F1F1Q38866722-CB356EAD-8879-4C7D-8943-8B1A3538A703Q38954343-52A3BC55-650E-4A9E-931E-CB25E84CF37FQ42721243-8C9D5F36-BEE9-4151-98C5-03D6999A7901Q46844304-356E9A32-D398-49F4-8D84-1390BB3C9105Q47566725-2C2086EE-9EF5-436C-BFCB-55F190CCF3D3Q47769675-C03792FD-828A-4E8A-91E8-44F8F7CEDEB8Q47847652-CAE17DFC-D6B7-496E-A86F-0332CA399B9DQ48479762-CF9197C3-028E-47DF-B2B6-2AEB19EE5961
P2860
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cutaneous melanoma: ESMO Clini ...... osis, treatment and follow-up.
@ast
Cutaneous melanoma: ESMO Clini ...... osis, treatment and follow-up.
@en
Cutaneous melanoma: ESMO Clini ...... osis, treatment and follow-up.
@nl
type
label
Cutaneous melanoma: ESMO Clini ...... osis, treatment and follow-up.
@ast
Cutaneous melanoma: ESMO Clini ...... osis, treatment and follow-up.
@en
Cutaneous melanoma: ESMO Clini ...... osis, treatment and follow-up.
@nl
prefLabel
Cutaneous melanoma: ESMO Clini ...... osis, treatment and follow-up.
@ast
Cutaneous melanoma: ESMO Clini ...... osis, treatment and follow-up.
@en
Cutaneous melanoma: ESMO Clini ...... osis, treatment and follow-up.
@nl
P2093
P2860
P356
P1433
P1476
Cutaneous melanoma: ESMO Clini ...... osis, treatment and follow-up.
@en
P2093
A Hauschild
ESMO Guidelines Working Group
G Pentheroudakis
M Guggenheim
U Keilholz
P2860
P304
P356
10.1093/ANNONC/MDS229
P478
23 Suppl 7
P577
2012-10-01T00:00:00Z